The presence of the UGT2B17 gene is associated with lung cancer in male Chinese han smokers

Genes and Genomics

Volumn 32, Issue 1, 2010, Pages 13-17

  Bai, Shuping ^a   Xu, Yang ^a   Wu, Lijie ^a   Li, Lejing ^a   Wang, Xiaohong ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Copy number variation; Lung cancer; UGT2B17

Indexed keywords

NICOTIANA TABACUM;

EID: 77956643955     PISSN: 19769571     EISSN: 20929293     Source Type: Journal    
DOI: 10.1007/s13258-010-0710-5     Document Type: Article

References (34)

1. Aitman TJ, Dong R, Vyse TJ, Norsworthy PJ, Johnson MD, Smith J, Mangion J, Roberton-Lowe C, Marshall AJ, Petretto E, et al. (2006) Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 439: 851-855.
2. Belinsky SA, Foley JF, White CM, Anderson MW and Maronpot RR (1990) Dose-response relationship between O6- methyl- guanine formation in Clara cells and induction of pulmonary neo- plasia in the rat by 4-(methylnitrosamino)-1-(3- pyridyl)-1- butanone. Cancer Res. 50: 3772-3780.
3. Biesalski HK, Bueno de Mesquita B, Chesson A, Chytil F, Grimble R, Hermus RJ, Kohrle J, Lotan R, Norpoth K, Pastorino U, et al. (1998) European Consensus Statement on Lung Cancer: risk factors and prevention. Lung Cancer Panel. CA Cancer J. Clin. 48: 167-176; discussion 164-166.
4. Carmella SG, Akerkar S and Hecht SS (1993) Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)- 1-butanone in smokers'urine. Cancer Res. 53: 721-724.
5. Carmella SG, Akerkar SA, Richie JP, Jr. and Hecht SS (1995) Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1- (3-pyridyl)-1-butanone (NNK) in smokers'urine. Cancer Epidemiol. Biomarkers Prev. 4: 635-642.
6. Carmella SG, Le Ka KA, Upadhyaya P and Hecht SS (2002) Analysis of N- and O-glucuronides of 4-(methylnitrosamino)-1-(3-pyr- idyl)-1-butanol (NNAL) in human urine. Chem. Res. Toxicol. 15: 545-550.
7. Freeman JL, Perry GH, Feuk L, Redon R, McCarroll SA, Altshuler DM, Aburatani H, Jones KW, Tyler-Smith C, Hurles ME, et al.(2006) Copy number variation: new insights in genome diversity.Genome Res. 16: 949-961. (Pubitemid 44162254)
8. Gallagher CJ, Kadlubar FF, Muscat JE, Ambrosone CB, Lang NP and Lazarus P (2007a) The UGT2B17 gene deletion polymorphism and risk of prostate cancer. A case-control study in Caucasians. Cancer Detect. Prev. 31: 310-315.
9. Gallagher CJ, Muscat JE, Hicks AN, Zheng Y, Dyer AM, Chase GA, Richie J and Lazarus P (2007b) The UDP-glucuronosyltransferase 2B17 gene deletion polymorphism: sex-specific association with urinary 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanol glucur-onidation phenotype and risk for lung cancer. Cancer Epidemiol. Biomarkers Prev. 16: 823-828.
10. Gonzalez E, Kulkarni H, Bolivar H, Mangano A, Sanchez R, Catano G, Nibbs RJ, Freedman BI, Quinones MP, Bamshad MJ, et al. (2005) The influence of CCL3L1 gene-containing segmental du-plications on HIV-1/AIDS susceptibility. Science 307: 1434-1440.
11. Hecht SS (1998) Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem. Res. Toxicol. 11: 559-603.
12. Hecht SS, Trushin N, Reid-Quinn CA, Burak ES, Jones AB, Southers JL, Gombar CT, Carmella SG, Anderson LM and Rice JM (1993) Metabolism of the tobacco-specific nitrosamine 4-(methylnitrosami-no)-1-(3-pyridyl)-1-butanone in the patas monkey: pharmacoki-netics and characterization of glucuronide metabolites. Carcino-genesis 14: 229-236.
13. Horikawa Y, Miyake K, Yasuda K, Enya M, Hirota Y, Yamagata K, Hinokio Y, Oka Y, Iwasaki N, Iwamoto Y, Yamada Y, et al. (2008) Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan. J. Clin. Endocrinol. Metab. 93: 3136-3141.
14. Jakobsson J, Ekstrom L, Inotsume N, Garle M, Lorentzon M, Ohlsson C, Roh HK, Carlstrom K and Rane A (2006) Large differences in testosterone excretion in Korean and SWEdish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism. J. Clin. Endocrinol. Metab. 91: 687-693.
15. Jin C, Miners JO, Lillywhite KJ and Mackenzie PI (1993) Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glu-curonidating carboxylic acid-containing drugs. J. Pharmacol. Exp. Ther. 264: 475-479.
16. Karypidis AH, Olsson M, Andersson SO, Rane A and Ekstrom L (2008) Deletion polymorphism of the UGT2B17 gene is associated with increased risk for prostate cancer and correlated to gene expression in the prostate. Pharmacogenomics J. 8: 147-151.
17. Lazarus P, Zheng Y, Aaron Runkle E, Muscat JE and Wiener D (2005) Genotype-phenotype correlation between the polymorphic UGT2B17 gene deletion and NNAL glucuronidation activities in human liver microsomes. Pharmacogenet. Genomics 15: 769-778.
18. Levesque E, Beaulieu M, Green MD, Tephly TR, Belanger A and Hum DW (1997) Isolation and characterization of UGT2B15 (Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics 7: 317-325.
19. Levesque E, Beaulieu M, Hum DW and Belanger A (1999) Characterization and substrate specificity of UGT2B4 (E458): a UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics 9: 207-216.
20. McCarroll SA, Hadnott TN, Perry GH, Sabeti PC, Zody MC, Barrett JC, Dallaire S, Gabriel SB, Lee C, Daly MJ, et al. (2006) Common deletion polymorphisms in the human genome. Nat. Genet. 38: 86-92.
21. Morse MA, Eklind KI, Toussaint M, Amin SG and Chung FL (1990) Characterization of a glucuronide metabolite of 4-(methyl-nitro-samino)-1-(3- pyridyl)-1-butanone (NNK) and its dose-dependent excretion in the urine of mice and rats. Carcinogenesis 11: 1819-1823.
22. Murata M, Warren EH and Riddell SR (2003) A human minor histo-compatibility antigen resulting from differential expression dueto a gene deletion. J. Exp. Med. 197: 1279-1289.
23. Olsson M, Lindström S, Häggkvist B, Adami HO, Bärter K, Stattin P, Ask B, Rane A, Ekström L and Grönberg H (2008) The UGT2B17 gene deletion is not associated with prostate cancer risk. Prostate 68: 571-575.
24. Park J, Chen L, Ratnashinge L, Sellers TA, Tanner JP, Lee J-H, Dossett N, Lang N, Kadlubar FF, Ambrosone CB, et al. (2006) Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men. Cancer Epidemiol. Biomarkers Prev. 15: 1473-1478.
25. Peto R, Lopez AD and Bereham J (2006) Mortality from smoking in developed countries 1950-2000: Indirect estimates from National Vital Statistics. Oxford University Press, Oxford.
26. Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD, Fiegler H, Shapero MH, Carson AR, Chen W, et al. (2006) Global variation in copy number in the human genome. Nature 444: 444-454.
27. Ritter JK, Sheen YY and Owens IS (1990) Cloning and expression of human liver UDP-glucuronosyltransferase in COS-1 cells. 3,4-catechol estrogens and estriol as primary substrates. J. Biol. Chem. 265: 7900-7906.
28. Spitz MR, Wei Q, Dong Q, Amos CI and Wu X (2003) Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiol. Biomarkers Prev. 12: 689-698. (Pubitemid 36993157)
29. Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazley C, Thorne N, Redon R, Bird CP, de Grassi A, Lee C, et al. (2007) Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 315: 848-853.
30. Swanson C, Mellström D, Lorentzon M, Vandenput L, Jakobsson J, Rane A, Karlsson M, Ljunggren Ö, Smith U, Eriksson AL, et al. (2007) The UDP Glucuronosyltransferase 2B15 D85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men. J. Clin. Endocrinol. Metab. 92: 4878-4882.
31. Tabara Y, Osawa H, Kawamoto R, Onuma H, Shimizu I, Miki T, Kohara K and Makino H (2009) Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening. Diabetes 58: 493-498.
32. Tephly TR and Burchell B (1990) UDP-glucuronosyltransferases: a family of detoxifying enzymes. Trends Pharmacol. Sci. 11: 276-279.
33. Wilson W III, Pardo-Manuel de Villena F, Lyn-Cook BD, Chatterjee PK, Bell TA, Detwiler DA, Gilmore RC, Valladeras IC, Wright CC, Threadgill DW, et al. (2004) Characterization of a common deletion polymorphism of the UGT2B17 gene linked to UGT2B15. Genomics 84: 707-714.
34. Xue Y, Sun D, Daly A, Yang F, Zhou X, Zhao M, Huang N, Zerjal T, Lee C, Carter NP, et al. (2008) Adaptive evolution of UGT2B17 copy-number variation. Am. J. Hum. Genet. 83: 337-346.